Golden Heaven Group Holdings Ltd. Enters into RMB15 Million Agreement for Management Solutions
NANPING, China, Jan. 8, 2025 /PRNewswire/ -- Golden Heaven Group Holdings Ltd. ("Golden Heaven" or the "Company") (Nasdaq: GDHG), an amusement park operator in China, today announced that Nanping Golden Heaven Amusement Park Management Co., Ltd....
Hedia and Glooko Partner to Elevate Diabetes Management with Personalised Bolus Insulin Dosing
New integration delivers personalised insulin dosing advice, improving care for people with diabetes and enhancing healthcare provider insights. COPENHAGEN, Denmark and PALO ALTO, Calif., Jan. 8, 2025 /PRNewswire/ -- Glooko, Inc. and Hedia, today...
Latest Updates of Viva Biotech's Portfolio Companies
HONG KONG, Jan. 8, 2025 /PRNewswire/ -- Recently, Viva Biotech's portfolio companies have new updates: TechnoDerma, VivaVision, Arthrosi, Apeiron Therapeutics and AceLink made solid progress in R&D; Full Circles published breakthrough results;...
I-Mab Announces Open Market Purchases of Company American Depositary Shares by Board Member
Chairman of the Board, Wei Fu, informed the Company of his intent to purchase up to $2,000,000 of the Company's American Depository Shares (ADSs) ROCKVILLE, Md., Jan. 8, 2025 /PRNewswire/ -- I-Mab (NASDAQ: IMAB) (the "Company"), a U.S.-based, global...
Canadian Solar's e-STORAGE to Deliver 2 GWh of Energy Storage Systems in the UK for Copenhagen Infrastructure Partners
KITCHENER, ON, Jan. 8, 2025 /PRNewswire/ -- Canadian Solar Inc. (the "Company" or "Canadian Solar") (NASDAQ: CSIQ) today announced that e-STORAGE, which is part of the Company's majority-owned subsidiary CSI Solar Co., Ltd. ("CSI Solar"), has signed...
Published in Annals of Oncology: Disitamab Vedotin Combined with PD-1 Inhibitor is a Promising Treatment for Locally Advanced or Metastatic Urothelial Carcinoma
YANTAI, China, Jan. 8, 2025 /PRNewswire/ -- On Janurary 7th, 2025, Annals of Oncology (IF: 56.7), a top oncology journal globally, published remarkable long-term follow-up results of a phase 1b/2 clinical trial on Disitamab Vedotin (DV) (developed...
Route Mobile Partners with PT MRT Jakarta to launch first-of-its-kind WhatsApp ticketing via vending machines and Email
MUMBAI, India, Jan. 8, 2025 /PRNewswire/ -- Route Mobile Limited ("Route Mobile"), a leading cloud communication platform service provider, has partnered with PT MRT Jakarta, Jakarta's premier urban rail transit provider, to launch an innovative,...
Hisense Transforms the Future of Home Entertainment and Smart Living with AI-powered Innovation at CES 2025
QINGDAO, China, Jan. 8, 2025 /PRNewswire/ -- Hisense, a leading brand in global consumer electronics and home appliances, unveiled the latest in AI-based technological innovation at its "AI Your Life" themed booth at CES 2025, captivating audiences...